Interleukin-7 and interleukin-15 as prognostic biomarkers in sepsis and septic shock: Correlation with inflammatory markers and mortality.

Inflammatory markers Interleukin 15 Interleukin 7 Mortality Sepsis Septic shock

Journal

Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353

Informations de publication

Date de publication:
09 2023
Historique:
received: 29 04 2023
revised: 07 06 2023
accepted: 09 06 2023
medline: 11 8 2023
pubmed: 23 6 2023
entrez: 22 6 2023
Statut: ppublish

Résumé

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection and a syndrome shaped by pathogen and host factors evolving over time. During sepsis, the absolute number of lymphocytes decreases. CD4+ and CD8+ T cells, B cells, and NK cells are reduced. Lymphocytes are an essential element of the body's defence against pathogens. Interleukin 7 has strong anti-apoptotic properties and induces the proliferation of CD4+ and CD8+ T lymphocytes. IL-15 prompts the generation of mature NK cells in the bone marrow, plays an important role in the generation, cytotoxicity, and survival of CD8+ T lymphocytes, and is essential for the survival of natural killer T (NKT) and intestinal intraepithelial lymphocytes (IELs). The study highlights the importance of monitoring IL-7 levels in patients with sepsis and septic shock, as low levels of this cytokine were associated with an increased risk of mortality. Physicians should consider using IL-7 levels as a biomarker to identify patients who are at higher risk of mortality and may require more aggressive treatment.

Identifiants

pubmed: 37348189
pii: S1043-4666(23)00155-2
doi: 10.1016/j.cyto.2023.156277
pii:
doi:

Substances chimiques

Interleukin-7 0
Interleukin-15 0
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

156277

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Patrycja Leśnik (P)

Department of Anaesthesiology and Intensive Therapy, 4th Military Clinical Hospital, 50-981 Wroclaw, Poland. Electronic address: patrycja.lesnik@gmail.com.

Jarosław Janc (J)

Department of Anaesthesiology and Intensive Therapy, 4th Military Clinical Hospital, 50-981 Wroclaw, Poland. Electronic address: jjanc@4wsk.pl.

Magdalena Mierzchala-Pasierb (M)

Department of Medical Biochemistry, Wroclaw Medical University, 50-369 Wroclaw, Poland. Electronic address: magdalena.mierzchala-pasierb@umw.edu.pl.

Wojciech Tański (W)

Department of Internal Medicine, 4th Military Clinical Hospital, 50-981 Wroclaw, Poland. Electronic address: dr.wojciech.tanski@gmail.com.

Jan Wierciński (J)

Department of Anaesthesiology and Intensive Therapy, 4th Military Clinical Hospital, 50-981 Wroclaw, Poland. Electronic address: jwiercinski@4wsk.pl.

Lidia Łysenko (L)

Department of Anaesthesiology and Intensive Therapy, Wroclaw Medical University, 50-556 Wroclaw, Poland. Electronic address: lidia.lysenko@umw.edu.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH